These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 13272794)
1. Chlorpromazine and human spasticity; an electromyographic study. BASMAJIAN JV; SZATMARI A Neurology; 1955 Dec; 5(12):856-60. PubMed ID: 13272794 [No Abstract] [Full Text] [Related]
2. Effect of largactil (chlorpromazine) on human spasticity and electromyogram; preliminary report. BASMAJIAN JV; SZATMARI A AMA Arch Neurol Psychiatry; 1955 Feb; 73(2):224-31. PubMed ID: 13227675 [No Abstract] [Full Text] [Related]
3. [Electromyographic research on spasticity and rigor. The behavior of the motoneurons during a chemically-induced increase in the activity of the muscle spindles]. STRUPPLER A; SCHULTE FJ; SCHEININGER R; KUKKU M Dtsch Z Nervenheilkd; 1961; 183():134-47. PubMed ID: 13917905 [No Abstract] [Full Text] [Related]
5. [CLINICAL AND ELECTROMYOGRAPHIC STUDIES IN 110 PATIENTS TREATED WITH A BENZODIAZEPINE DERIVATIVE]. CIBEIRA JB; BUZZI A; DOMINELLI JC Prensa Med Argent; 1964 Dec; 51():1544-73. PubMed ID: 14272084 [No Abstract] [Full Text] [Related]
6. [MEDICAL TREATMENT OF SPASTICITY]. PEDERSEN E Nord Med; 1964 Jan; 71():17-20. PubMed ID: 14103689 [No Abstract] [Full Text] [Related]
7. An electromyographic analysis of spasticity. Lance JW; Burke D; Gillies JD Trans Am Neurol Assoc; 1970; 95():272-4. PubMed ID: 5514389 [No Abstract] [Full Text] [Related]
8. [Chlorpromazine and spasticity; an experimental electrophysiological study]. HENATSCH HD; INGVAR DH Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr; 1956; 195(1):77-93. PubMed ID: 13373396 [No Abstract] [Full Text] [Related]
9. [CONTRIBUTION TO THE EVALUATION OF SPASTICITY BY POLYELECTROMYOGRAPHY]. VELE F; JANDA V Cesk Neurol; 1964 Jan; 27():24-5. PubMed ID: 14128773 [No Abstract] [Full Text] [Related]
10. [Clinical and electromyographic studies on the pharmacological control of spasms]. Zschocke S; Brune G Verh Dtsch Ges Inn Med; 1965; 71():662-5. PubMed ID: 5877680 [No Abstract] [Full Text] [Related]
11. THE NATURE AND MANAGEMENT OF SPASTICITY. THE PATHOPHYSIOLOGY OF SPASTICITY. RUSHWORTH G Proc R Soc Med; 1964 Aug; 57(8):715-20. PubMed ID: 14195868 [No Abstract] [Full Text] [Related]
12. [Myotonolysis by means of orphenadrine citrate. Clinical and electromyographic studies in cerebral and spinal spasticity]. Steinbrecher W Arzneimittelforschung; 1966 Feb; 16(2):147-53. PubMed ID: 6014007 [No Abstract] [Full Text] [Related]
13. [Electroencephalographic, electrodermatographic and electromyographic changes induced by chlorpromazine]. TURNER M; BERARD E; TURNER N; FRANCO N Anesth Anal; 1955 Jun; 12(3):453-65. PubMed ID: 15444840 [No Abstract] [Full Text] [Related]
14. Phenytoin and chlorpromazine in the treatment of spasticity. Cohan SL; Raines A; Panagakos J; Armitage P Arch Neurol; 1980 Jun; 37(6):360-4. PubMed ID: 6248002 [TBL] [Abstract][Full Text] [Related]